By Aduragbemi Omiyale The board of Neimeth International Pharmaceuticals Plc can raise an additional N30 billion from the capital market, shareholders have declared. They gave the...
By Aduragbemi Omiyale The board and management of Neimeth International Pharmaceuticals Plc have been praised for enhancing operations, promoting business continuity, and restoring investor confidence. This...
By Dipo Olowookere Last week, the trio of Neimeth International Pharmaceutical Plc, Universal Insurance Plc and Fidelity Bank Plc dominated the activity chart of the Nigerian...
By Dipo Olowookere Last week, on the floor of the Nigerian Exchange (NGX) Limited, Neimeth International Pharmaceuticals, Transcorp, and UBA were the most active stocks as...
By Dipo Olowookere The performance of the Nigerian Exchange (NGX) Limited was lukewarm on Tuesday as investors set their eyes on Christmas sales. This brought about...
By Dipo Olowookere Persistent profit-taking further chopped off 0.24 per cent from the Nigerian Exchange (NGX) Limited on Tuesday as investors sold off shares that have...
By Dipo Olowookere The rights issue of Neimeth International Pharmaceuticals Plc aimed to raise about N3.67 billion from the capital market has now been extended by...
By Dipo Olowookere The board of Neimeth International Pharmaceuticals Plc has decided to raise N5 billion from two sources; rights issue and private placement. This decision...
By Adedapo Adesanya Neimeth International Pharmaceuticals has kicked off a public enlightenment campaign to create awareness against the rampaging coronavirus disease. This was done in collaboration...
By Dipo Olowookere One of the healthcare shares on the Nigerian Stock Exchange (NSE), Neimeth International Pharmaceuticals Plc, seems to have ended its honeymoon at the...
